Your browser doesn't support javascript.
loading
Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial.
Macle, Laurent; Khairy, Paul; Weerasooriya, Rukshen; Novak, Paul; Verma, Atul; Willems, Stephan; Arentz, Thomas; Deisenhofer, Isabel; Veenhuyzen, George; Scavée, Christophe; Jaïs, Pierre; Puererfellner, Helmut; Levesque, Sylvie; Andrade, Jason G; Rivard, Lena; Guerra, Peter G; Dubuc, Marc; Thibault, Bernard; Talajic, Mario; Roy, Denis; Nattel, Stanley.
Afiliación
  • Macle L; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada. Electronic address: lmacle@mac.com.
  • Khairy P; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Weerasooriya R; University of Western Australia and Hollywood Private Hospital, Perth, WA, Australia.
  • Novak P; Royal Jubilee Hospital, Victoria, BC, Canada.
  • Verma A; Southlake Regional Health Centre, Newmarket, ON, Canada.
  • Willems S; University Hospital Eppendorf, Hamburg, Germany.
  • Arentz T; Herz-Zentrum, Bad Krozingen, Germany.
  • Deisenhofer I; Deutsches Herz-Zentrum Munchën, Munich, Germany.
  • Veenhuyzen G; Libin Cardiovascular Institute, Calgary, AB, Canada.
  • Scavée C; Cliniques Universitaires St-Luc, Brussels, Belgium.
  • Jaïs P; Hôpital Haut-Lévèque, Bordeaux, France.
  • Puererfellner H; KH der Elisabethinen, Linz, Austria.
  • Levesque S; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Andrade JG; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Rivard L; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Guerra PG; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Dubuc M; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Thibault B; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Talajic M; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Roy D; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Nattel S; Montreal Heart Institute and Montreal Health Innovations Coordinating Centre, Department of Medicine, Université de Montréal, Montreal, QC, Canada.
Lancet ; 386(9994): 672-9, 2015 Aug 15.
Article en En | MEDLINE | ID: mdl-26211828
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Adenosina / Ablación por Catéter / Antiarrítmicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Adenosina / Ablación por Catéter / Antiarrítmicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido